Mindray’s Q1 Results a Disappointment

Mindray Medical, the medical equipment maker, reported Q1 revenues rose a modest 9% to $145.8 million while net income was $36.2 million ($40.1 million, non-GAAP). Interestingly, sales for from China were flat, though international revenues climbed 17%. Mindray said international revenues from emerging markets were exceptionally strong, though it did not provide specific numbers. Following the announcement, Mindray’s share price dropped $4.07 to $30.93, a 12% fall, in early, very volatile trading. More details... Stock Symbol: (NYSE: MR)